Skip to main content

quotable quotes - July 2011

Published: 7/5/11

on the risks and benefits of diabetes therapies

"Despite tremendous advances in diabetes therapies, people with diabetes still experience considerable challenges and risks everyday. We can do better – and make safer and more effective therapies available now."
- Aaron Kowalski, PhD (Juvenile Diabetes Research Foundation, New York, NY) emphasizing that the risks and benefits of new therapies must be considered in light of the risks and benefits of diabetes as it can be managed currently during a session titled “The Future of Regulation and Monitoring of Drugs and Devices for Diabetes” at this year’s American Diabetes Association Scientific Sessions in San Diego.

on advocacy for anti-obesity drugs

"To the extent that this community just watches, we are an enemy as well."
- Alexander Fleming, MD (Kinexum, Harpers Ferry, WV) commenting on the need for members of the community to raise awareness about the need for anti-obesity medications during a session titled “Challenges and Expectations for Obesity Pharmacotherapy” at this year’s American Diabetes Association Scientific Sessions in San Diego.

on low glucose suspend

"Quite frankly, there is no risk of diabetic ketoacidosis."
- Thomas Danne, MD (Hannover Medical School, Hannover, Germany) on low glucose suspend in the Medtronic Paradigm Veo during a session titled “Automated Insulin Delivery Systems – Are They Ready for Prime Time?” at this year’s American Diabetes Association Scientific Sessions in San Diego.

What do you think?